1. Home
  2. APRE vs SUP Comparison

APRE vs SUP Comparison

Compare APRE & SUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • SUP
  • Stock Information
  • Founded
  • APRE 2006
  • SUP 1957
  • Country
  • APRE United States
  • SUP United States
  • Employees
  • APRE N/A
  • SUP N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • SUP Auto Parts:O.E.M.
  • Sector
  • APRE Health Care
  • SUP Consumer Discretionary
  • Exchange
  • APRE Nasdaq
  • SUP Nasdaq
  • Market Cap
  • APRE 10.0M
  • SUP 10.0M
  • IPO Year
  • APRE 2019
  • SUP N/A
  • Fundamental
  • Price
  • APRE $1.71
  • SUP $0.12
  • Analyst Decision
  • APRE Strong Buy
  • SUP
  • Analyst Count
  • APRE 2
  • SUP 0
  • Target Price
  • APRE $15.50
  • SUP N/A
  • AVG Volume (30 Days)
  • APRE 50.9K
  • SUP 722.7K
  • Earning Date
  • APRE 08-11-2025
  • SUP 08-07-2025
  • Dividend Yield
  • APRE N/A
  • SUP N/A
  • EPS Growth
  • APRE N/A
  • SUP N/A
  • EPS
  • APRE N/A
  • SUP N/A
  • Revenue
  • APRE $1,284,475.00
  • SUP $1,272,670,000.00
  • Revenue This Year
  • APRE N/A
  • SUP $3.52
  • Revenue Next Year
  • APRE N/A
  • SUP $3.66
  • P/E Ratio
  • APRE N/A
  • SUP N/A
  • Revenue Growth
  • APRE 33.27
  • SUP N/A
  • 52 Week Low
  • APRE $1.41
  • SUP $0.30
  • 52 Week High
  • APRE $5.01
  • SUP $3.66
  • Technical
  • Relative Strength Index (RSI)
  • APRE 52.34
  • SUP 19.21
  • Support Level
  • APRE $1.48
  • SUP $0.11
  • Resistance Level
  • APRE $1.91
  • SUP $0.35
  • Average True Range (ATR)
  • APRE 0.16
  • SUP 0.05
  • MACD
  • APRE -0.00
  • SUP 0.03
  • Stochastic Oscillator
  • APRE 63.14
  • SUP 4.88

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About SUP Superior Industries International Inc. (DE)

Superior Industries International Inc is engaged in the design and manufacture of aluminum wheels for sale to OEMs in North America and Europe and to the aftermarket in Europe. The company's OEM aluminum wheels are sold for factory installation on vehicle models manufactured by BMW (including Mini), Daimler (Mercedes-Benz, AMG, Smart), Ford, GM, Honda, Jaguar-Land Rover, Lucid Motors, Mazda, Nissan, PSA, Renault, Stellantis, Subaru, Suzuki, Toyota, VW Group (Volkswagen, Audi, SEAT, Skoda, Porsche, Bentley) and Volvo. It sells aluminum wheels to the European aftermarket under the brands ATS, RIAL, ALUTEC, and ANZIO. Geographically, Company's reportable segments are North America and Europe. Key revenue is generated from North America.

Share on Social Networks: